Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4663 S-cw3554
Novel irriversible selective PDI inhibitor, selectively labeling protein disulfide isomerase and inhibiting its enzymatic activity, showing unique cytotoxicity in cells derived from multiple myeloma
More description
DCC4662 Scriptene
NRTI-drug pair of zidovudine (AZT)-didanosine (ddI), being highly cytotoxic and mutagenic
More description
DCC4661 Scr-4026
Novel inhibitor of nNOS-PSD-95 interaction, exhibiting neuroprotective activities in NMDA-induced or Oxygen and glucose deprivation (OGD)-induced neuronal damage in primary cortical neurons cultures, and ameliorating focal cerebral ischemic damage in rats
More description
DCC4660 Scr1693
Novel dual acetylcholinesterase inhibitor (AChEI) and a calcium channel blocker (CCB)
More description
DCC4659 Scq-14d
Novel Inhibitor of p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs) with the IC50 values of 140, 910 and 17.5 nmol/L against MDM2, HDAC1, and HDAC6, respectively, showing the tumor growth inhibition (TGI) in the A549 xenograf
More description
DCC4658 scio-469 Hydrochloride
Selective, ATP-competitive p38
More description
DCC4657 Schembl20148701
Novel inhibitor of SARS-CoV-2 main protease (MPro)
More description
DCC4656 Schembl18616095
Novel inhibitor of SARS-CoV-2 main protease (MPro)
More description
DCC4655 Schembl18320671
Novel glucose transport inhibitor
More description
DCC4654 Schembl15939407
Novel Lysine-Specific Demethylase 1 (LSD1) Inhibitor (IC50: 20nM)
More description
DCC4653 Schembl1548848
Novel inhibitor of vanilloid receptor subtype 1 (VR1)
More description
DCC4652 Schembl12616233
Novel inhibitor of SARS-CoV-2 main protease (MPro)
More description
DCC4651 Sch-900822
Novel potent and selective glucagon receptor antagonist
More description
DCC4650 sch-79687
Novel histamine H3-receptor antagonist
More description
DCC4649 Sch-53870
Inhibitor of p21-hRas nucleotide exchange in vitro
More description
DCC4648 Sch-538415
Novel Acyl_carrier_protein_synthase>acyl carrier protein synthase inhibitor; Inhibitor of growth of the bacteria Streptococcus_pneumoniae>Streptococcus pneumoniae and Neisseria_gonorrhoeae>Neisseria gonorrhoeae
More description
DCC4647 Sch-51866
Potent and selective PDE1 and PDE5 inhibitor
More description
DCC4646 Sch-43478
Non-​nucleoside antiviral agent, having potent and selective activity against herpes simplex virus type 2 (HSV-​2)
More description
DCC4645 Sch-351591
Novel, orally active phosphodiesterase 4 (PDE4) inhibitor
More description
DCC4644 Sch-23985
D1 dopamine receptor antagonist
More description
DCC4643 Sch-23982
Precursor for radioiosotopically labelled R(+)-SCH-23390
More description
DCC4642 Sch2-1-27
Novel Inhibitor of the virus fusion to its cell receptor, targeting SARS-CoV-2 spike protein HR1
More description
DCC4641 Sch2-1-20
Novel Inhibitor of the virus fusion to its cell receptor, targeting SARS-CoV-2 spike protein HR1
More description
DCC4640 Sch-202596
Natural selective non-peptide antagonist for the receptor GAL-1
More description
DCC4639 Scalaradial
Natural Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels
More description
DCC4638 Scacer2
Novel photoswitchable substrate for sphingomyelin synthase 2 (SMS2), enabling optical control of apoptosis and being ready for azide-alkyne click chemistry
More description
DCC4637 Scacer1
Novel photoswitchable substrate for sphingomyelin synthase 2 (SMS2), enabling optical control of apoptosis and being ready for azide-alkyne click chemistry
More description
DCC4636 Sc-75416
Novel selective COX-2 inhibitor
More description
DCC4635 Sc-68376
Potent and selective inhibitor of p38 MAP kinase
More description
DCC4634 Sc-558
Selective COX-2 inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X